Discussion GLP-1RAs have changed the therapeutic paradigm of T2D as they significantly improve glucose control, also contributing to pleiotropic effects, especially at the cardiovascular level (60), in different clinical scenarios and therapeutic approaches
Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands
doi: 10.5230/jgc.2015.15.1.10 7 HooiJKYLaiWYNgWKSuenMMYUnderwoodFETanyingohDet al
Clinician Support: A licensed clinician oversees your treatment, manages your prescription, and is available for ongoing guidance throughout your program
2016;13(2):S17785
Certain genetic conditions affecting sulfur metabolism may warrant caution